United Guardian (UG) Total Current Liabilities (2010 - 2026)
United Guardian's (UG) quarterly Total Current Liabilities came in at $1.7 million in Q2 2026, down 6.27% year-over-year from $1.9 million in Q2 2025, and up 18.45% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
United Guardian (UG) Total Current Liabilities (2010 - 2026) Analysis & Trends
United Guardian has disclosed Total Current Liabilities across 17 years of filings, most recently posting $1.7 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 6.27% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $1.7 million (down 6.27% YoY), while the FY2025 annual figure was $1.7 million, down 12.81% from the prior year.
- Total Current Liabilities came in at $1.7 million for Q2 2026 at United Guardian, up from $1.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $2.0 million in Q1 2022 to a low of $1.4 million in Q4 2022.
- Average Total Current Liabilities over 5 years is $1.7 million, with a median of $1.7 million recorded in 2026.
- The largest YoY upside for Total Current Liabilities was 36.75% in 2022 against a maximum downside of 41.24% in 2022.
- Over 5 years, Total Current Liabilities stood at $1.4 million in 2022, then rose by 11.69% to $1.5 million in 2023, then advanced by 24.78% to $1.9 million in 2024, then fell by 12.81% to $1.7 million in 2025, then increased by 4.07% to $1.7 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $1.7 million in Q2 2026, $1.5 million in Q1 2026, and $1.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn | 32.65 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 37.11 Bn |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | 354.06 Mn |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 1.31 Bn |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn | 607.80 Mn |
| 10 | United Guardian | 32.97 Mn | 23.37 Mn | 1.55 Mn | 1.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.66 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Mar 31, 2022 | 2.01 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 1.45 Mn |